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Tramadol is nowadays one of the most commonly
abused drugs in Iran. In our country, few emergency
physicians have never visited a tramadol-intoxicated
patient referring after overdose or with side effects of its
use. One of the complications of tramadol use, abuse, or
overdose is seizure [1-4]. It has been shown that the
tramadol-induced seizures are not dose-dependent [5].
To date, the incidence rate of recurrent/multiple seizures
in tramadol-intoxicated patients has been determined in
several studies as shown in Table 1 [3,6-11]. The
important question is that is there a need for prophylac-
tic administration of anticonvulsants in tramadol-
intoxicated patients referring with an initial seizure? Of
note, in some poison treatment centers of Iran, adminis-
tration of benzodiazepine is a routine treatment in such
patients. As you know, in the setting of clinical toxicol-
ogy, except for the intravenous overdose of vincristine
[12], severe toxicity with methylxanthines [13], strych-
nine toxicity [14], and withdrawal of ethanol and some
benzodiazepines [15], no other condition exists for
whose prevention of recurrent or multiple seizures,
prophylactic anticonvulsants have been recommended
[16]. This certainly applies to the tramadol-induced
seizures, as well, because these seizures have no special
characteristic for which we believe them to be different
from other drug- and toxin-induced seizures. For in-
stance, tramadol-induced seizures are tonic-clonic,
short-lived, and self-limited similar to the most of other
drug-induced seizures [16]. In addition, in the setting of
poisoning, even where there is the likelihood of
recurrent seizures (except for the above-mentioned
conditions), prophylactic administration of the anticon-
vulsants has not been recommended and in the case ofCorrespondence: h-sanaiezadeh@tums.ac.ir
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reproduction in any medium, provided the ordevelopment of such seizures, they are treated similarly
to a single episode [16]. Therefore, prophylactic admin-
istration of anticonvulsant appears to be unnecessary
even if the patients have an initial seizure. In addition,
the cost-effectiveness of such unnecessary treatment
should not be forgotten. Also, as you know, there is not
a standardized management protocol for tramadol tox-
icity. For example, with respect to the possibility of the
occurrence of seizure or apnea, how long does the phys-
ician need to observe the patients? Should activated
charcoal be administrated after tramadol overdose? [17]
Should naloxone be given to the comatose tramadol-
intoxicated patients? [2,3,18,19] This highlights the role
of global act by doing more research to fix the problem
of tramadol [20,21].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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